Benzoylcarbamic acid

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: Benzoylcarbamic acid
• 化学式: C₈H₇NO₃
• 分子量: 165.15
• InChiKey: TWVMOBWHILUBSS-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.8
• 重原子数：
  12
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  66.4
• 氢给体数：
  2
• 氢受体数：
  3

文献信息

• BACE INHIBITORS
  申请人：Eli Lilly and Company

  公开号：US20140371212A1

  公开（公告）日：2014-12-18

  The present invention provides a compound of Formula III: wherein A is: and Z, R 1 , R 2 , R 3 , and R 4 are as defined herein, or a pharmaceutically acceptable salt thereof.

  本发明提供了一种III式化合物：其中A是：以及Z、R1、R2、R3和R4如本文所定义，或其药学上可接受的盐。
• PYRROLIDINE DERIVATIVES
  申请人：GHIDINI Eleonora

  公开号：US20110201580A1

  公开（公告）日：2011-08-18

  The present invention relates to novel anti-inflammatory and antiallergic compounds of the glucocorticosteroid series, methods of preparing such compounds, pharmaceutical compositions comprising them, combinations and therapeutic uses thereof. More particularly, the invention relates to glucocorticosteroids that are derivatives of pyrrolidine.

  本发明涉及新型糖皮质激素系列的抗炎和抗过敏化合物，制备此类化合物的方法，包含它们的药物组合物，它们的组合和治疗用途。更具体地，本发明涉及吡咯烷衍生物的糖皮质激素。
• Luminescent compounds
  申请人：Patsenker D. Leonid

  公开号：US20080076188A1

  公开（公告）日：2008-03-27

  Reporter compounds based on aromatic and heterocyclic compounds, including intermediates used to synthesize the reporter compounds, and methods of synthesizing and using the reporter compounds, where the reporter compounds generally have the structure: where at least one pair of adjacent substituents (R a , R b ), (R b , R c ), (R c , R d ), (R d , R e ), (R e , R f ), (R f , R a ) is either a substituted cyclic or polycyclic group; or at least one set of three substituents (R a , R b , R c ), (R b , R c , R d ), (R c , R d , R e ), (R d , R e , R f ), (R e , R f , R a ) is a substituted cyclic or polycyclic group.

  基于芳香和杂环化合物的报告化合物，包括用于合成报告化合物的中间体，以及合成和使用报告化合物的方法，其中报告化合物通常具有以下结构：至少有一对相邻的取代基（Ra，Rb），（Rb，Rc），（Rc，Rd），（Rd，Re），（Re，Rf），（Rf，Ra）中的一对要么是取代的环或多环基团；或者至少有一组三个取代基（Ra，Rb，Rc），（Rb，Rc，Rd），（Rc，Rd，Re），（Rd，Re，Rf），（Re，Rf，Ra）是取代的环或多环基团。
• Compounds to treat Alzheimer's disease
  申请人：——

  公开号：US20030013881A1

  公开（公告）日：2003-01-16

  The present invention is directed toward substituted hydroxyethylene compounds of formulas (XII) (XIII), and (XIV) 1 useful in treating Alzheimer's disease and other similar diseases.

  本发明涉及用于治疗阿尔茨海默病和其他类似疾病的式（XII）、（XIII）和（XIV）的替代羟基乙烯化合物。
• Ionic Liquids for Separation of Olefin-Paraffin Mixtures
  申请人：Dai Sheng

  公开号：US20110015461A1

  公开（公告）日：2011-01-20

  The invention is directed to an ionic liquid comprising (i) a cationic portion containing a complex of a silver (I) ion and one or more neutral ligands selected from organoamides, organoamines, olefins, and organonitriles, and (ii) an anionic portion having the chemical formula wherein m and n are independently 0 or an integer of 1 or above, and p is 0 or 1, provided that when p is 0, the group —N—SO 2 —(CF 2 ) n CF 3 subtended by p is replaced with an oxide atom connected to the shown sulfur atom. The invention is also directed to a method for separating an olefin from an olefin-paraffin mixture by passing the mixture through a layer of the ionic liquid described above.

  该发明涉及一种离子液体，包括（i）含有银（I）离子的阳离子部分，该离子与来自有机酰胺、有机胺、烯烃和有机腈中选择的一个或多个中性配体形成的络合物，以及（ii）具有化学式的阴离子部分，其中m和n独立地为0或大于1的整数，p为0或1，但当p为0时，由p支撑的基团—N—SO2—(CF2)nCF3将被连接到所示硫原子的氧原子替代。该发明还涉及一种从烯烃烷烃混合物中分离烯烃的方法，通过将混合物经过上述离子液体的一层来实现。